Individuals with type 1 diabetes who were not obese showed a fourfold increased risk for dementia (hazard ratio [HR], 4.0; 95 ...

Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

Alzheimer's patients have been dealt a blow after disappointing results from a major trial. Novo Nordisk has announced that ...

Lots of vegetables, olive oil, nuts, whole grains, and occasional fish–these foods form the core of not only my diet but also ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...

One of the most devastating moments for family members of a patient with Alzheimer’s is when their loved one forgets who they ...

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Scientists hail ‘very exciting’ findings that explain why Alzheimer’s patients forget their loved ones, and say drugs are ...

Johnson & Johnson will discontinue the Phase II Auτonomy study of posdinemab after a scheduled review found the anti-tau ...